Bright Minds Biosciences Book Value Per Share Growth & History (DRUG)
Bright Minds Biosciences's book value per share was CA$10.74 for fiscal 2025.
View full Bright Minds Biosciences company overviewBright Minds Biosciences annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | CA$10.74 | CA$9.52 | +778.02% |
| 2024 | 2024-09-30 | CA$1.22 | -CA$0.25 | −17.21% |
| 2023 | 2023-09-30 | CA$1.48 | CA$0.88 | +146.66% |
| 2022 | 2022-09-30 | CA$0.60 | -CA$1.04 | −63.45% |
| 2021 | 2021-09-30 | CA$1.64 | CA$1.44 | +712.07% |
| 2020 | 2020-09-30 | CA$0.20 | — | — |
Bright Minds Biosciences quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | CA$31.37 | CA$24.05 | +328.78% |
| Q2 2026 | 2026-03-31 | CA$31.44 | CA$23.57 | +299.56% |
| Q1 2026 | 2025-12-31 | CA$11.47 | — | — |
| Q4 2025 | 2025-09-30 | CA$10.74 | CA$9.52 | +778.02% |
| Q3 2025 | 2025-06-30 | CA$7.32 | — | — |
| Q2 2025 | 2025-03-31 | CA$7.87 | — | — |
| Q4 2024 | 2024-09-30 | CA$1.22 | -CA$0.25 | −17.21% |
| Q4 2023 | 2023-09-30 | CA$1.48 | CA$0.88 | +146.66% |
| Q4 2022 | 2022-09-30 | CA$0.60 | -CA$1.04 | −63.45% |
| Q4 2021 | 2021-09-30 | CA$1.64 | — | — |
Bright Minds Biosciences book value per share trends
Over the last five fiscal years, Bright Minds Biosciences's book value per share increased from CA$0.20 to CA$10.74, a change of CA$10.54. The latest reported quarter, Q3 2026, shows CA$31.37.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bright Minds Biosciences source filings ↗